RadNet (NASDAQ:RDNT) Stock Price Crosses Below 50-Day Moving Average - Here's Why

RadNet logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell below the 50-day moving average: RadNet traded as low as $71.50 and last changed hands at $71.82, below its 50-day average of $72.92.
  • Quarterly results were mixed: RadNet reported adjusted earnings of $0.30 per share, beating estimates of $0.22, while revenue of $638.26 million came in slightly below expectations; revenue rose 22.1% year over year.
  • Analyst sentiment remains broadly positive: The stock carries a “Moderate Buy” consensus rating and an average price target of $89.67, though ratings range from Strong Buy to Sell.
  • MarketBeat previews the top five stocks to own by December 1st.

RadNet, Inc. (NASDAQ:RDNT - Get Free Report)'s share price passed below its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $72.92 and traded as low as $71.50. RadNet shares last traded at $71.82, with a volume of 811,588 shares traded.

Wall Street Analyst Weigh In

Several brokerages recently commented on RDNT. Weiss Ratings reissued a "sell (d-)" rating on shares of RadNet in a research report on Wednesday, November 4th. Jefferies Financial Group reaffirmed a "buy" rating on shares of RadNet in a report on Friday, July 31st. Barclays upped their target price on shares of RadNet from $65.00 to $79.00 and gave the stock an "overweight" rating in a research note on Friday, August 28th. Zacks Research downgraded shares of RadNet from a "strong-buy" rating to a "hold" rating in a research note on Monday, November 9th. Finally, Truist Financial increased their price target on shares of RadNet from $90.00 to $94.00 and gave the company a "buy" rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $89.67.

Read Our Latest Stock Report on RDNT

RadNet Stock Performance

The business's fifty day moving average price is $72.92 and its 200-day moving average price is $65.56. The stock has a market cap of $5.66 billion, a PE ratio of -247.66 and a beta of 1.42. The company has a debt-to-equity ratio of 0.90, a quick ratio of 1.49 and a current ratio of 1.49.

RadNet (NASDAQ:RDNT - Get Free Report) last issued its quarterly earnings data on Sunday, November 8th. The medical research company reported $0.30 earnings per share for the quarter, beating analysts' consensus estimates of $0.22 by $0.08. RadNet had a negative net margin of 0.94% and a positive return on equity of 3.14%. The company had revenue of $638.26 million for the quarter, compared to the consensus estimate of $639.97 million. During the same quarter in the prior year, the firm earned $0.20 earnings per share. The firm's revenue for the quarter was up 22.1% compared to the same quarter last year. As a group, equities research analysts forecast that RadNet, Inc. will post 0.56 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Mital Patel sold 44,661 shares of the stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $78.51, for a total transaction of $3,506,335.11. Following the transaction, the executive vice president directly owned 155,514 shares of the company's stock, valued at $12,209,404.14. This represents a 22.31% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 5.14% of the company's stock.

Institutional Trading of RadNet

Large investors have recently modified their holdings of the company. Global Retirement Partners LLC lifted its holdings in RadNet by 285.2% in the third quarter. Global Retirement Partners LLC now owns 470 shares of the medical research company's stock valued at $32,000 after acquiring an additional 348 shares during the period. Farther Finance Advisors LLC boosted its position in RadNet by 60.2% in the third quarter. Farther Finance Advisors LLC now owns 596 shares of the medical research company's stock worth $41,000 after purchasing an additional 224 shares during the last quarter. Hantz Financial Services Inc. boosted its position in RadNet by 18.8% in the third quarter. Hantz Financial Services Inc. now owns 872 shares of the medical research company's stock worth $60,000 after purchasing an additional 138 shares during the last quarter. Parallel Advisors LLC boosted its position in RadNet by 80.0% in the first quarter. Parallel Advisors LLC now owns 1,114 shares of the medical research company's stock worth $62,000 after purchasing an additional 495 shares during the last quarter. Finally, Nykredit A S purchased a new position in RadNet in the second quarter worth about $153,000. Institutional investors own 77.90% of the company's stock.

About RadNet

(Get Free Report)

RadNet, Inc. operates outpatient diagnostic imaging centers in the United States. Its centers provide services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound, X-ray and nuclear medicine imaging. The company serves patients, physicians and healthcare organizations, with operations across several states, including California, Delaware, Florida, Maryland, New Jersey and New York. Its imaging centers offer diagnostic services for a range of medical needs, from routine screening to specialized examinations.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in RadNet Right Now?

Before you consider RadNet, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RadNet wasn't on the list.

While RadNet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines